Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study.

摘要: Abstract Observations by health-care professionals suggest that the use of anabolic androgenic steroids (AAS) may be associated with lethal complications, but this has not yet been confirmed controlled epidemiological studies. Here, we investigated diagnoses (in Swedish patient care records) and mortality rate among patients who tested positively for presence AAS (n = 248) in connection receiving medical care. Patients had negatively (n = 1215) were used comparison. The proportions received institutionalized substance abuse, psychiatric disorder or central thoracic pain significantly higher AAS-positive subjects (RR = 2.2, 95% CI = 1.2–4.2; RR = 2.1, CI = 1.4–3.2 RR = 3.5, CI = 1.1–10.9, respectively). Furthermore, unspecified convulsions highly over-represented group (RR=53.9, CI = 7.0–415.7) one these died during a seizure. standardized ratios (SMR) -negative 20.43 (95% CI = 10.56–35.70) 6.02 CI = 3.77–9.12), respectively. relatively SMR was observed irrespective what type clinic referred testing. In conclusion, appears to an indicator increased risk premature death several categories patients. However, nature association between remains unclear additional research on question is urgently required.